
Actinic keratosis: how field-directed treatments compare
Actinic keratosis is a precursor to squamous cell carcinoma. What the progression data show, and how fluorouracil, imiquimod, and photodynamic therapy compared in a head-to-head trial.
Dr. SangYoul Yun is a Korean board-certified dermatologist who medically reviews DermatologyNews articles.

Actinic keratosis is a precursor to squamous cell carcinoma. What the progression data show, and how fluorouracil, imiquimod, and photodynamic therapy compared in a head-to-head trial.

Standard microfocused ultrasound protocols are single-session. What the evidence says about repeating treatment, combining devices in one visit, and why patient and investigator ratings diverge.

The rough bumps on upper arms and thighs are common and harmless. What trials show about keratolytics, lasers, and intense pulsed light, and why recurrence is the expected outcome.

An emerging dermatophyte species is poorly responsive to terbinafine and cannot be identified without molecular testing. What the resistance data show and what they change in practice.
Baricitinib, ritlecitinib, and deuruxolitinib are FDA approved for severe alopecia areata. Compare age limits, trials, boxed warnings, and evidence gaps.
Clascoterone is an FDA-approved topical androgen receptor inhibitor for acne. See the phase 3 results, limits, adverse effects, and unanswered comparisons.
Delgocitinib cream is FDA approved for some adults with chronic hand eczema. Review the phase 3 results, label limits, safety warnings, and evidence gaps.
The FDA received reports of serious complications with certain RF microneedling uses in 2025. Learn what was reported, remains unknown, and how needling differs.
Lebrikizumab and nemolizumab target different atopic dermatitis pathways. Compare their FDA labels, phase 3 designs, safety limits, and evidence gaps.
Ruxolitinib cream can improve facial repigmentation in some people with nonsegmental vitiligo. Review the FDA label, trial outcomes, timeline, and risks.

Hypochlorous acid face spray is popular, but human evidence mainly comes from wound care. See what HOCl may do, what remains unproven, and safety limits.
Mechanism, efficacy data, downtime, and the post-inflammatory hyperpigmentation risk that dominates ablative fractional CO2 resurfacing for atrophic acne scars, with a focus on darker and Asian skin.